Clinical Trial Update: Testing TH-302, in Combination With Preoperative Chemoradiotherapy, in Esophageal Cancer. [Phase 1]

View source ↗

Summary

A Phase 1 trial of TH-302 (evofosfamide) in combination with preoperative chemoradiotherapy for esophageal cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Evofosfamide (evofosfamide)

Snippet

Sponsor: Maastricht Radiation Oncology | Conditions: Esophageal Cancer | Phase 1 | Status: WITHDRAWN